Skip to main content
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in via EAHP
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Current issue
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Current issue
Archive
Authors
About
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in via EAHP
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Online First
Budget impact analysis of bevacizumab biosimilars for cancer treatment in adult patients in Spain
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
PDF +
Supplementary
Material
Original research
Budget impact analysis of bevacizumab biosimilars for cancer treatment in adult patients in Spain
Online download statistics by month:
Online download statistics by month: November 2021 to July 2022
Abstract
Full
Pdf
Nov 2021
351
344
133
Dec 2021
269
267
78
Jan 2022
245
248
42
Feb 2022
114
120
40
Mar 2022
146
146
75
Apr 2022
189
191
48
May 2022
150
149
28
Jun 2022
155
165
30
Jul 2022
144
147
51
Total
1763
1777
525
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in via EAHP
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
PDF